ARCHIVES

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

This article is from The Cancer Letter archive.

Vol. 40 No. 03 | January 17, 2014

Download PDF Visit The Full Archive

Related Articles

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

Foti Receives Del Duca Award; Wake Forest To Hire 60 Faculty.

February 11, 2000

$20 Million In Construction Funds Approved

April 2, 1976

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988